Back
Structure Therapeutics Vs. Altimmune Industry Stock Comparison
Buy
59
GPCR
Structure Therapeutics
Last Price:
38.26
Seasonality Move:
120.41%
Buy
57
ALT
Altimmune
Last Price:
7.43
Seasonality Move:
0.83%
Buy
59
Structure Therapeutics (GPCR)
is a Buy
Is Structure Therapeutics a Buy, Sell or Hold?
- The current Structure Therapeutics [GPCR] share price is $38.44. The Score for GPCR is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- GPCR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Altimmune (ALT)
is a Buy
Is Altimmune a Buy, Sell or Hold?
- The current Altimmune [ALT] share price is $7.57. The Score for ALT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- ALT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GPCR Stock Price Chart
What is Structure Therapeutics's stock price today?
-
The Structure Therapeutics share price today is $38.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing selling pressure, which indicates risk of future bearish movement.
GPCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.28 | Buy |
Relative Strength Index (14 RSI): | 50.17 | Buy |
Chaikin Money Flow: | -357004 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (36.54 - 40.36) | Sell |
Bollinger Bands (100): | (34.68 - 45.06) | Sell |
ALT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.23 | Buy |
Relative Strength Index (14 RSI): | 61 | Buy |
Chaikin Money Flow: | -1409699 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.33 - 7.27) | Buy |
Bollinger Bands (100): | (6.24 - 7.54) | Buy |
GPCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.25 | Buy |
20-day SMA: | 38.84 | Sell |
50-day SMA: | 38.19 | Buy |
200-day SMA: | 41.49 | Sell |
8-day EMA: | 38.88 | Sell |
20-day EMA: | 38.46 | Sell |
50-day EMA: | 38.68 | Sell |
200-day EMA: | 39.63 | Sell |
ALT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.1 | Buy |
20-day SMA: | 6.86 | Buy |
50-day SMA: | 6.72 | Buy |
200-day SMA: | 8.05 | Sell |
8-day EMA: | 7.25 | Buy |
20-day EMA: | 6.93 | Buy |
50-day EMA: | 6.81 | Buy |
200-day EMA: | 7.09 | Buy |
Structure Therapeutics Earnings Growth & GPCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.08 per share, an increase this year of $0.08 per share, and an increase next year of $0.08 per share.
Altimmune Earnings Growth & ALT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.02 per share, an increase this year of $0.66 per share, and a decrease next year of $0.29 per share.
Structure Therapeutics Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Altimmune Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |